Found 107 matching trials
Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE PHASE3 This is an open-label, single-dose, single-arm, single-center imaging study...
Show More Location
Excel Diagnostics and Nuclear Oncology Center
Learn More & Join Trial
64Cu-DOTATATE-PET for Lyme Neuroborreliosis NA The aim of the study is to investigate the applicability and performance of...
Show More Location
Anne-Mette Lebech
Learn More & Join Trial
Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome PHASE2 Between 10% and 15% of patients with endogenous hypercortisolism (Cushing s...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Symptomatic and Systemic Atherosclerotic Plaque Activity in Patients With Peripheral Arterial Disease Using Novel Imaging N/A The goal of this observational study is to characterise the relationships b...
Show More Location
Royal Infirmary of Edinburgh
Learn More & Join Trial
18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor EARLY_PHASE1 The aim of this study is to evaluate the diagnostic performance and tumor b...
Show More Location
Peking union medical college hospital
Learn More & Join Trial
Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake PHASE2 The goal of this clinical trial is to evaluate an investigational ultralow ...
Show More Location
Nuclear Imaging Institute
Learn More & Join Trial
68Ga-DOTATATE PET Scan in Neuroendocrine Cancer PHASE2 Neuroendocrine cancer is an unusual disease and often goes undetected by ro...
Show More Location
Vanderbilt University Medical Center
Learn More & Join Trial
Using Novel Imaging to More Safely Treat Neuroendocrine Tumors PHASE1 The goal of this research is to determine if DetectnetTM PET/CT can be used...
Show More Location
University of Wisconsin - Madison
Learn More & Join Trial
Lesion-to-lesion Comparison of 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT in the Evaluation of Metastatic Neuroendocrine Tumors PHASE2 This study is a single centre non-randomized non-blinded phase II prospecti...
Show More Status
Active Not Recruiting
Location
University of Alberta Hospital
Learn More & Join Trial
Evaluation of the Inflammation-based Index as a Predictive Marker of Clinical and Radiological Response in Patients Treated With Lu-177 Oxodotreotide for Intestinal Neuroendocrine Tumour NA This is a prospective, multicenter, open-label study designed to evaluate t...
Show More Location
Institut de Cancérologie de l'Ouest
Learn More & Join Trial